Q2 2023 Seres Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics' second quarter earnings conference call. (Operator Instructions)
I would now like to turn the conference over to Dr. Carlo Tanzi, Head of Investor Relations. Please go ahead.
Thank you, and good morning. Our press release for the Company's second quarter 2023 financial results and a business update became available at 7 a.m. Eastern Time this morning and can be found on the Investors and News section of the Company's website.
I'd like to remind you that we will be making forward-looking statements including the commercial success of the VOWST, the timing and results of clinical studies, the ability for microbiome therapeutics to modulate the microbiome and treat or prevent infection, our ability to achieve sales targets and the receipt of future milestones and debt tranches, and other statements which are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
